CD56bright natural killer (NK) cells: an important NK cell subset

被引:726
作者
Poli, Aurelie [1 ]
Michel, Tatiana [1 ]
Theresine, Maud [1 ]
Andres, Emmanuel [2 ]
Hentges, Francois [1 ]
Zimmer, Jacques [1 ]
机构
[1] CRP Sante, Lab Immunogenet Allergol, L-1526 Luxembourg, Luxembourg
[2] Hop Univ Strasbourg, Serv Med Interne, Clin Med B, Strasbourg, France
关键词
CD56(bright); immunoregulation; natural killer cells; HUMAN CYTOMEGALOVIRUS-INFECTION; PERIPHERAL-BLOOD; RHEUMATOID-ARTHRITIS; RECEPTOR EXPRESSION; GENE-EXPRESSION; ACTIVATION; CD56(DIM); SUBPOPULATIONS; DYSFUNCTION; CD94/NKG2C;
D O I
10.1111/j.1365-2567.2008.03027.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human natural killer (NK) cells can be subdivided into different populations based on the relative expression of the surface markers CD16 and CD56. The two major subsets are CD56(bright) CD16(dim/-) and CD56(dim) CD16(+), respectively. In this review, we will focus on the CD56(bright) NK cell subset. These cells are numerically in the minority in peripheral blood but constitute the majority of NK cells in secondary lymphoid tissues. They are abundant cytokine producers but are only weakly cytotoxic before activation. Recent data suggest that under certain conditions, they have immunoregulatory properties, and that they are probably immediate precursors of CD56(dim) NK cells. CD56(bright) NK cell percentages are expanded or reduced in a certain number of diseases, but the significance of these variations is not yet clear.
引用
收藏
页码:458 / 465
页数:8
相关论文
共 50 条
[31]   Loss of CCR7 Expression on CD56bright NK Cells Is Associated with a CD56dimCD16+ NK Cell-Like Phenotype and Correlates with HIV Viral Load [J].
Hong, Henoch S. ;
Ahmad, Fareed ;
Eberhard, JohannaM. ;
Bhatnagar, Nupur ;
Bollmann, Benjamin A. ;
Keudel, Phillip ;
Ballmaier, Matthias ;
Zielinska-Skowronek, Margot ;
Schmidt, Reinhold E. ;
Meyer-Olson, Dirk .
PLOS ONE, 2012, 7 (09)
[32]   Monocytes inhibit hepatitis C virus-induced TRAIL expression on CD56bright NK cells [J].
Mele, Dalila ;
Mantovani, Stefania ;
Oliviero, Barbara ;
Grossi, Giulia ;
Lombardi, Andrea ;
Mondelli, Mario U. ;
Varchetta, Stefania .
JOURNAL OF HEPATOLOGY, 2017, 67 (06) :1148-1156
[33]   IL15 Infusion of Cancer Patients Expands the Subpopulation of Cytotoxic CD56bright NK Cells and Increases NK-Cell Cytokine Release Capabilities [J].
Dubois, Sigrid ;
Conlon, Kevin C. ;
Mueller, Juergen R. ;
Hsu-Albert, Jennifer ;
Beltran, Nancy ;
Bryant, Bonita R. ;
Waldmann, Thomas A. .
CANCER IMMUNOLOGY RESEARCH, 2017, 5 (10) :929-938
[34]   Ovarian Cancer-Associated Ascites Have High Proportions of Cytokine-Responsive CD56bright NK Cells [J].
Tonetti, Claudia Rodrigues ;
de Souza-Araujo, Caroline Natania ;
Yoshida, Adriana ;
da Silva, Rodrigo Fernandes ;
Alves, Paulo Cesar Martins ;
Mazzola, Tais Nitsch ;
Derchain, Sophie ;
Fernandes, Luis Gustavo Romani ;
Guimaraes, Fernando .
CELLS, 2021, 10 (07)
[35]   Cytotoxicity of Human Hepatic Intrasinusoidal CD56bright Natural Killer Cells against Hepatocellular Carcinoma Cells [J].
Hwang, Shin ;
Han, Jaeseok ;
Baek, Ji-Seok ;
Tak, Eunyoung ;
Song, Gi-Won ;
Lee, Sung-Gyu ;
Jung, Dong-Hwan ;
Park, Gil-Chun ;
Ahn, Chul-Soo ;
Kim, Nayoung .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (07)
[36]   CD56bright CD25+ NK cells are preferentially recruited to the maternal/fetal interface in early human pregnancy [J].
Tao, Yu ;
Li, Yan-Hong ;
Piao, Hai-Lan ;
Zhou, Wen-Jie ;
Zhang, Di ;
Fu, Qiang ;
Wang, Song-Cun ;
Li, Da-Jin ;
Du, Mei-Rong .
CELLULAR & MOLECULAR IMMUNOLOGY, 2015, 12 (01) :77-86
[37]   Human Natural Killer Cell Maturation Defect Supports In Vivo CD56bright to CD56dim Lineage Development [J].
Ines Domaica, Carolina ;
Beatriz Fuertes, Mercedes ;
Uriarte, Ignacio ;
Victoria Girart, Maria ;
Sardanons, Jessica ;
Ileana Comas, Dorina ;
Di Giovanni, Daniela ;
Isabel Gaillard, Maria ;
Bezrodnik, Liliana ;
Walter Zwirner, Norberto .
PLOS ONE, 2012, 7 (12)
[38]   Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential [J].
Koopman, LA ;
Kopcow, HD ;
Rybalov, B ;
Boyson, JL ;
Orange, JS ;
Schatz, F ;
Masch, R ;
Lockwood, CJ ;
Schachter, AD ;
Park, PJ ;
Strominger, JL .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (08) :1201-1212
[39]   Plerixafor effectively mobilizes CD56bright NK cells in blood, providing an allograft predicted to protect against GVHD [J].
Wong, Peggy P. C. ;
Kariminia, Amina ;
Jones, David ;
Eaves, Connie J. ;
Foley, Ronan ;
Ivison, Sabine ;
Couban, Stephen ;
Schultz, Kirk R. .
BLOOD, 2018, 131 (25) :2863-2866
[40]   CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset [J].
Lopez-Verges, Sandra ;
Milush, Jeffrey M. ;
Pandey, Suchitra ;
York, Vanessa A. ;
Arakawa-Hoyt, Janice ;
Pircher, Hanspeter ;
Norris, Philip J. ;
Nixon, Douglas F. ;
Lanier, Lewis L. .
BLOOD, 2010, 116 (19) :3865-3874